Please sign in with your existing account details.
Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.
Privacy statement - Terms and conditions
Forgotten your password?
You have exceeded the maximum number of login attempts for this email address and your account has been locked. An email has been sent to member of Browne Jacobson's web team and some one will be contacting you over the next two working days with details of how to change your password.
Are you sure you want to remove this item from you pinned content?
One of the most anticipated points in the Queen’s speech last week was the announcement of the Education and Adoption Bill. The proposed legislation would give the education secretary the power to intervene in so-called 'coasting' schools, defined by the Department for Education as those “having shown a prolonged period of mediocre performance and insufficient pupil progress”. No further information is given about how long a 'prolonged period' is or what would constitute 'insufficient' pupil progress.
As contributors to a Guardian article point out, schools regularly achieving good results and therefore over-subscribed may be as guilty of failing to maximise their student’s potential as those regularly at the bottom of the league tables. The new bill may mark the first step away from an over-reliance on exam results and towards contextual value added as a marker for both potential and achievement for students and schools.
The new definition may bring some surprises for staff and parents who previously thought their school safe from unwanted DfE attention.
With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.
View blog
The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.
Our top tips for supporting transgender and non-binary pupils.
On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.
Associate
Select which mailings you would like to receive from us.
Sign up